My Quote Request
No products added yet
6505-01-158-3628
20 Products
NDC63304-0744-01
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505011583628
NSN
6505-01-158-3628
NDC63304-0744-01
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505011583628
NSN
6505-01-158-3628
MFG
RANBAXY PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENOBARBITAL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
EVAC-Q-KWIK
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011584346
NSN
6505-01-158-4346
EVAC-Q-KWIK
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011584346
NSN
6505-01-158-4346
MFG
SAVAGE LABORATORIES DIV OF ALTANA INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAXATIVE KIT PRERADIOGRAPHIC EXAMINATION
TEST CAPABILITY QUANTITY: 1
USAGE DESIGN: FOR USE AS A BOWEL EVACUANT
Related Searches:
NDC00013-2189-00
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011584346
NSN
6505-01-158-4346
NDC00013-2189-00
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011584346
NSN
6505-01-158-4346
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAXATIVE KIT PRERADIOGRAPHIC EXAMINATION
TEST CAPABILITY QUANTITY: 1
USAGE DESIGN: FOR USE AS A BOWEL EVACUANT
Related Searches:
NDC00281-0297-76
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011584346
NSN
6505-01-158-4346
NDC00281-0297-76
LAXATIVE KIT,PRERADIOGRAPHIC EXAMINATION
NSN, MFG P/N
6505011584346
NSN
6505-01-158-4346
MFG
SAVAGE LABORATORIES DIV OF ALTANA INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAXATIVE KIT PRERADIOGRAPHIC EXAMINATION
TEST CAPABILITY QUANTITY: 1
USAGE DESIGN: FOR USE AS A BOWEL EVACUANT
Related Searches:
NDC00025-2742-31
DISOPYRAMIDE PHOSPH
NSN, MFG P/N
6505011586361
NSN
6505-01-158-6361
MFG
PHARMACIA & UPJOHN INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 150 MG DISOPYRAMIDE PHOSPHATE EQUIVALENT; 100 CAPSULES PER BOTTLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DISOPYRAMIDE PHOSPHATE EXTENDED-RELEASE CAPSULES 150MG 100S BT
Related Searches:
NORPACE CR
DISOPYRAMIDE PHOSPH
NSN, MFG P/N
6505011586361
NSN
6505-01-158-6361
MFG
SEARLE G D AND CO
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 150 MG DISOPYRAMIDE PHOSPHATE EQUIVALENT; 100 CAPSULES PER BOTTLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DISOPYRAMIDE PHOSPHATE EXTENDED-RELEASE CAPSULES 150MG 100S BT
Related Searches:
NDC00002-1691-25
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011586811
NSN
6505-01-158-6811
NDC00002-1691-25
PROTAMINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011586811
NSN
6505-01-158-6811
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
LANATUSS EXPECTORANT
CHLORPHENIRAMINE MALEATE,GUAIFENESIN,PHENYLPROPANOLAMINE HYDROCHLORIDE,AND SODIUM CITRATE SYRUP
NSN, MFG P/N
6505011586812
NSN
6505-01-158-6812
LANATUSS EXPECTORANT
CHLORPHENIRAMINE MALEATE,GUAIFENESIN,PHENYLPROPANOLAMINE HYDROCHLORIDE,AND SODIUM CITRATE SYRUP
NSN, MFG P/N
6505011586812
NSN
6505-01-158-6812
MFG
LANNETT CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.400 MILLIGRAMS CHLORPHENIRAMINE MALEATE PER MILLILITER AND 20.000 MILLIGRAMS GUAIFENESIN PER MILLILITER AND 1.000 MILLIGRAMS PHENYLPROPANOLAMINE HYDROCHLORIDE PER MILLILITER AND 39.400 MILLIGRAMS SODIUM CITRATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 128.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALCOHOL-FREE AND SUGAR-FREE
STABILIZER: BUFFERING AGENT
Related Searches:
NDC00527-0808-28
CHLORPHENIRAMINE MALEATE,GUAIFENESIN,PHENYLPROPANOLAMINE HYDROCHLORIDE,AND SODIUM CITRATE SYRUP
NSN, MFG P/N
6505011586812
NSN
6505-01-158-6812
NDC00527-0808-28
CHLORPHENIRAMINE MALEATE,GUAIFENESIN,PHENYLPROPANOLAMINE HYDROCHLORIDE,AND SODIUM CITRATE SYRUP
NSN, MFG P/N
6505011586812
NSN
6505-01-158-6812
MFG
LANNETT CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.400 MILLIGRAMS CHLORPHENIRAMINE MALEATE PER MILLILITER AND 20.000 MILLIGRAMS GUAIFENESIN PER MILLILITER AND 1.000 MILLIGRAMS PHENYLPROPANOLAMINE HYDROCHLORIDE PER MILLILITER AND 39.400 MILLIGRAMS SODIUM CITRATE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 128.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALCOHOL-FREE AND SUGAR-FREE
STABILIZER: BUFFERING AGENT
Related Searches:
1A6626
AMINO ACID INJECTION
NSN, MFG P/N
6505011586813
NSN
6505-01-158-6813
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 40.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 87.000 MILLIEQUIVALENTS ACETATE PER LITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACID INJECTION 2000ML BOTTLE W/HANGING DEVICE 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.65 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00338-0629-06
AMINO ACID INJECTION
NSN, MFG P/N
6505011586813
NSN
6505-01-158-6813
NDC00338-0629-06
AMINO ACID INJECTION
NSN, MFG P/N
6505011586813
NSN
6505-01-158-6813
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 40.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 87.000 MILLIEQUIVALENTS ACETATE PER LITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACID INJECTION 2000ML BOTTLE W/HANGING DEVICE 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.65 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
TRAVASOL 10%
AMINO ACID INJECTION
NSN, MFG P/N
6505011586813
NSN
6505-01-158-6813
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT AND 40.000 MILLIEQUIVALENTS CHLORIDE PER LITER AND 87.000 MILLIEQUIVALENTS ACETATE PER LITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACID INJECTION 2000ML BOTTLE W/HANGING DEVICE 6S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.65 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS INJECTION SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC01490-0039-04
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505011587615
NSN
6505-01-158-7615
NDC01490-0039-04
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505011587615
NSN
6505-01-158-7615
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 262.000 MILLILITERS BISMUTH SUBSALICYLATE 15 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBSALICYLATE 120ML OR 4FL OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 MILLILITERS OR 4.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALSO CONTAINS THE FOLLOWING PER 15 ML: 130 MG TOTAL SALICYLATE AND 5 MG TOTAL SODIUM; PALATABLY FLAVORED,AQUEOUS,SUGAR-FREE; WITH CHILD-RESISTANT SAFETY CLOSURE; NOTE: F
Related Searches:
NDC00071-4180-35
THROMBIN,USP
NSN, MFG P/N
6505011587627
NSN
6505-01-158-7627
MFG
WARNER-LAMBERT LLC DBA PFIZER DIV INSITITUIONAL SALES
Description
DERIVATION: BOVINE
DILUTING AGENT: STERILE ISOTONIC SODIUM CHLORIDE SOLUTION NOT FOR PARENTERAL USE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THROMBIN USP BOVINE DERIVATION 20000UN AND 20ML DILUENT/PG
QUANTITY WITHIN EACH UNIT PACKAGE: 20000.000 UNITS AND 20.000 MILLILITERS
SPECIAL FEATURES: STERILE ISOTONIC SODIUM CHLORIDE SOLUTION NOT FOR PARENTERAL USE; LYOPHILIZED; FOR TOPICAL USE ONLY; THE UNIT OF ISSUE SHALL CONSIST OF 1 STERILE VIAL CONTAINING 20000 UNITS OF DRIED THROMBIN USP,AND 1 VIAL CONTAINING NOT LESS THAN 200 ML OF STERILE
UNIT PACKAGE CONTENTS: THROMBIN AND ISOTONIC SODIUM CHLORIDE SOLUTION
UNIT PACKAGE QUANTITY: 2
UNIT PACKAGE TYPE: PACKAGE
~1: ISOTONIC SALINE DILUENT,PG TOGETHER IN A SUITABLE CARTON OR CONTAINER
Related Searches:
NDC52604-7105-03
THROMBIN,USP
NSN, MFG P/N
6505011587627
NSN
6505-01-158-7627
MFG
MONARCH PHARMACEUTICALS INC
Description
DERIVATION: BOVINE
DILUTING AGENT: STERILE ISOTONIC SODIUM CHLORIDE SOLUTION NOT FOR PARENTERAL USE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THROMBIN USP BOVINE DERIVATION 20000UN AND 20ML DILUENT/PG
QUANTITY WITHIN EACH UNIT PACKAGE: 20000.000 UNITS AND 20.000 MILLILITERS
SPECIAL FEATURES: STERILE ISOTONIC SODIUM CHLORIDE SOLUTION NOT FOR PARENTERAL USE; LYOPHILIZED; FOR TOPICAL USE ONLY; THE UNIT OF ISSUE SHALL CONSIST OF 1 STERILE VIAL CONTAINING 20000 UNITS OF DRIED THROMBIN USP,AND 1 VIAL CONTAINING NOT LESS THAN 200 ML OF STERILE
UNIT PACKAGE CONTENTS: THROMBIN AND ISOTONIC SODIUM CHLORIDE SOLUTION
UNIT PACKAGE QUANTITY: 2
UNIT PACKAGE TYPE: PACKAGE
~1: ISOTONIC SALINE DILUENT,PG TOGETHER IN A SUITABLE CARTON OR CONTAINER
Related Searches:
CYTOXAN
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
CYTOXAN
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 45 MG SODIUM CHLORIDE PER 100 MG CYCLOPHOSPHAMIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00013-5636-70
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
NDC00013-5636-70
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 45 MG SODIUM CHLORIDE PER 100 MG CYCLOPHOSPHAMIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00015-0505-41
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
NDC00015-0505-41
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 45 MG SODIUM CHLORIDE PER 100 MG CYCLOPHOSPHAMIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NEOSAR
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
NEOSAR
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505011587889
NSN
6505-01-158-7889
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 45 MG SODIUM CHLORIDE PER 100 MG CYCLOPHOSPHAMIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00407-0044-01
METRIZAMIDE FOR INJECTION
NSN, MFG P/N
6505011588001
NSN
6505-01-158-8001
NDC00407-0044-01
METRIZAMIDE FOR INJECTION
NSN, MFG P/N
6505011588001
NSN
6505-01-158-8001
MFG
GE HEALTH DBA GE HEALTHCARE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.750 GRAMS METRIZAMIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METRIZAMIDE FOR INJECTION 3.75GM IN A 20ML SINGLE DOSE VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 3.750 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: W/20 ML VIAL STERILE AQUEOUS DILUENT; IN A 20 ML-SIZE SINGLE DOSE VIAL
